Thursday, 1 October 2026Updated 3m ago
← Top stories
Market move▼ Bearish for Apollo Hospitals

Hospital stocks extend losses as drug-pricing regulation concerns linger; Apollo, Max among top Nifty losers

1 source · first seen 09:25 1 Oct · updated 09:25 1 Oct

Tags on this story

Pick a tag to see all its stories
Hospitals11 todayUS drug pricing1 todayApollo Hospitals₹8,165.50 · 12 todayMax Healthcare₹929.80 · 9 todayPharma and healthcare34 today

Linked by the tag US drug pricing

6 stories this week
  1. 29 SeptNifty Pharma defies market slump as select drugs get US tariff exemptionMarket move · 3 sources · Qualifying speciality medicines from India will be eligible for zero US duty
  2. 28 SeptUS exempts select Indian specialty drugs and ingredients from its 100% pharma tariffPolicy · 7 sources · The exemption covers certain specialty drugs and ingredients from India and 19 other countries
  3. 28 SeptPharma sector eyes 10% growth in FY27 as domestic market offsets US slowdown1 source
  4. 26 SeptOncologist calls for five-year plan to widen access to precision cancer carePolicy · 2 sources · The proposed agenda would expand access to genomic testing and targeted cancer therapies for lower-income patients
All US drug pricing stories →
Part of a developing story6 updates over 2 days

Hospital drug markups and pricing regulation concerns

The Supreme Court questioned hospital markups on cancer drugs, including a case where a medicine costing ₹2,700 to retailers was billed at ₹27,000 to patients, and urged a probe. Hospital stocks fell sharply, erasing $2.6 billion in value, as investors weighed possible medicine price curbs.

Thursday, 1 October

  1. You are here
    Hospital stocks extend losses as drug-pricing regulation concerns linger; Apollo, Max among top Nifty losers
  2. Hospital stocks sell-off a buying opportunity or a risk? Here is what analysts advice
  3. Could Apollo, Fortis, Max Health Face A Profit Hit From Medicine Price Curbs? Jefferies, BofA, Macquarie Weigh In

Wednesday, 30 September

  1. 2 sources
    Supreme Court flags hospital cancer-drug markups; hospital stocks lose $2.6 billion
  2. 4 sources
    SC questions hospital drug mark-ups; hospital stocks fall up to 7%
  3. 3 sources
    Hospital stocks fall after Supreme Court questions steep patient markups

Follow the full storyline →

Read the reports

1 report · earliest 09:25
MoneycontrolHospital stocks extend losses as drug-pricing regulation concerns linger; Apollo, Max among top Nifty losers09:25